WHO EML Cancer Medicines Working Group (CMWG)

Overview

At the Seventieth World Health Assembly in 2017, World Health Organization (WHO) Member States adopted resolution WHA70.12, Cancer prevention and control in the context of an integrated approach, and WHO was requested to prepare a technical report on pricing approaches for cancer medicines for presentation to the Executive Board. An informal advisory group meeting was convened by WHO in April 2018 to obtain relevant input from experts nominated by all WHO Regional Offices. The consultation aimed to provide expert advice on the scope of the report, on the benefits and consequences of various pricing approaches for cancer medicines and on options for improving the availability and affordability of cancer medicines.